Portfolio company
Five Alarm Bio
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops small-molecule therapeutics to strengthen cellular defences against chemical damage for patients with age-related conditions and chronic wounds.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Etheros
This company develops small molecule enzyme-mimetic drugs to prevent oxidative and inflammatory injury for patients with neurodegenerative and age-related conditions.
Rubedo Life Sciences
This company develops small-molecule therapeutics and anti-ageing skin care products for patients with age-related diseases and consumers seeking skin rejuvenation.
Integrated Biosciences
The company develops small-molecule therapies for age-related diseases using a synthetic biology and machine learning platform to target cellular stress responses.
Endurance Bio
This biotechnology company develops oral small molecule therapeutics for patients with neurodegenerative and metabolic diseases to restore mitochondrial and lysosomal health.
BioAge Labs
This company develops therapeutic drugs targeting the biology of human aging to treat patients with metabolic and cardiovascular diseases.
ClotProtect
This therapeutics company develops a small molecule drug to treat acute bleeding and improve survival for patients suffering from trauma or undergoing surgery.
Cleara Biotech
The company develops peptide-based therapies that target and eliminate senescent cells to treat patients with late-stage cancers and age-related chronic diseases.
Rubedo.Life
This company develops small-molecule prodrugs that selectively eliminate senescent cells for patients with age-related chronic diseases and skin conditions.
